Showing 8301-8310 of 9426 results for "".
- Exuviance Launches Age Less Everyday Daily Moisturizerhttps://practicaldermatology.com/news/20130912-exuviance_launches_age_less_everydaydaily_moisturizer/2459462/NeoStrata Company, Inc., recently introduced Exuviance Age Less Everyday, a daily moisturizer formulated to correct the signs of aging for skin that is dry, sensitive, or easily impacted by everyday stressors. Exuviance Age Less Everyday is formulated w
- FDA Approves Botox Cosmetic to Treat Crow's Feet Lines in Adultshttps://practicaldermatology.com/news/20130912-fda_approves_botox_cosmetic_to_treat_crows_feet_lines_in_adults/2459463/The FDA recently approved Botox Cosmetic (onabotulinumtoxinA) for an additional indication to temporarily treat moderate to severe lateral canthal lines. Allergan's
- Roche's Erivedge OK'd in Canadahttps://practicaldermatology.com/news/20130827-roches_erivedge_okd_in_canada/2459474/Erivedge (vismodegib) was recently approved in Canada for the treatment of adult patients with histologically confirmed metastatic basal cell carcinoma or locally advanced basal cell carcinoma inappropriate for surgery or radiotherapy.
- Psoriasis Foundation Urges CMS to Halt Proposed Cuts to Phototherapy Reimbursementhttps://practicaldermatology.com/news/20130815-psoriasis_foundation_urges_cms_to_halt_proposed_cuts_to_phototherapy_reimbursement/2459477/The National Psoriasis Foundation has stepped up efforts to halt the Centers for Medicare and Medicaid Services (CMS) plan to cut reimbursement rates to phototherapy in the proposed CY 2014 Medicare Physician Fee Schedule (PFS). According to the Foundation, if the proposed cuts pass, many physicians
- Iagnosis, Inc., Launches Mobile App for DermatologistOnCall®https://practicaldermatology.com/news/20130815-iagnosis_inc_launches_mobile_app_for_dermatologistoncall/2459479/A new app for an online dermatology platform has recently launched from Iagnosis, Inc. The DermatologistOnCall® app, based on the website www.dermatologistoncall.com, enables to create an account and submit photographs and descriptions of their condition. Patients then receive a response from a boar
- Merz North America Appoints New Chief Financial Officerhttps://practicaldermatology.com/news/20130807-merz_north_america_appoints_new_chief_financial_officer/2459482/Merz North America has appointed John Donofrio as Chief Financial Officer and Head of Business Development - North America. In this role, Donofrio will be primarily accountable for financial performance, cost management, and strategic business planning and analysis for the Finance organization in No
- Differin Gel Found Effective in Adult Women with Acnehttps://practicaldermatology.com/news/20130807-differin_gel_found_effective_in_adult_women_with_acne/2459483/At the recent AAD Summer Meeting in New York, Galderma Laboratories presented results showing that Differin® (adapalene) Gel, 0.3% is efficacious in reducing acne lesions in adult women, and has been proven superior in reducing inflammatory lesions in women compared with vehicle gel. Investigators u
- Alphaeon Acquires US License To Teoxane Laboratories' Dermal Fillers And Cosmeceutical Productshttps://practicaldermatology.com/news/20130802-alphaeon_acquires_us_license_to_teoxane_laboratories_dermal_fillers_and_cosmeceutical_products/2459484/Alphaeon Corporation, a wholly-owned subsidiary of Strathspey Crown Holdings, LLC, has acquired an exclusive US license for the full line of products from Teoxane Laboratories. Containing 100 percent non-animal origin, resorbable hyaluronic acid, Teoxane's dermal fillers are currently available in m
- Valeant Unveils Advanced Deep Cleansing Duo for Acnehttps://practicaldermatology.com/news/20130730-valeant_unveils_advanced_deep_cleansing_duo_for_acne/2459487/Valeant Pharmaceuticals is has added additional products to its new AcneFree product line. Rounding out AcneFree's daily cleansing option are the AcneFree Advanced Cleansing Brush and AcneFree Oil-Free Purifying Cleanser. The Cleansing Brush features a two-speed rotating brush head to exfoliate and
- FDA Limits Use of Nizoralhttps://practicaldermatology.com/news/20130730-fda_limits_use_of_nizoral/2459489/The FDA has limited the use of Nizoral (ketoconazole) oral tablets, warning that the oral tablets can cause severe liver injuries and adrenal gland problems and advising that it can lead to harmful drug interactions with other medications. FDA has approved label changes and added a new Medication Gu